SCHEMBL7706904

SCHEMBL7706904

Nc1ccc(OC(F)C(F)(F)OC(F)(F)F)c(Cl)c1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.36
TSHR P16473 2/20 0.36
MRGPRX4 Q96LA9 1/20 0.35
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CSNK2A1 P68400 2/20 0.33
RORC P51449 1/20 0.32
ALDH1A1 P00352 1/20 0.30
THRB P10828 1/20 0.30
HPGD P15428 1/20 0.30
ALOX15 P16050 1/20 0.30
CASP1 P29466 1/20 0.30
RECQL P46063 1/20 0.30
HSD17B10 Q99714 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3649852 0.77 CYP3A4 (0.46) CYP3A4TSHRCA1CA2CSNK2A1
SCHEMBL7575949 0.76 CYP3A4 (0.36) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL9447561 0.76 MEN1 (0.44) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL236764 0.73 CYP3A4 (0.46) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL30140163 0.73 CYP3A4 (0.46) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL11307249 0.73 CYP3A4 (0.39) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL28351619 0.73 MEN1 (0.42) CYP3A4TSHRMRGPRX4CA1CA2
SCHEMBL4964188 0.70 ALDH1A1 (0.45) CYP3A4TSHRCA1CA2CSNK2A1
SCHEMBL10702989 0.70 PDE7A (0.41) ALDH1A1HPGDMEN1KMT2A
SCHEMBL2103199 0.70 CSNK2A1 (0.61) CYP3A4TSHRCA1CA2CSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1207869-A2 ANTIMYCOTIC DRUG Novartis AG (CH) 2002-05-29 EP claimed
WO-2001015684-A2 ANTIMYCOTIC DRUG NOVARTIS AG (CH) 2001-03-08 WO claimed
EP-1080722-A1 Antimycotic compositions Novartis AG (CH) 2001-03-07 EP claimed
EP-1207869-A2 ANTIMYCOTIC DRUG Novartis AG (CH) 2002-05-29 EP disclosed
WO-2001015684-A2 ANTIMYCOTIC DRUG NOVARTIS AG (CH) 2001-03-08 WO disclosed
EP-1080722-A1 Antimycotic compositions Novartis AG (CH) 2001-03-07 EP disclosed